参考文献/References:
[1]DAY C P, JAMES O F W. Steatohepatitis: a tale of two “hits”?[J]. Gastroenterology, 1998, 114(4): 842-845.
[2]HIROTSU Y, KATSUOKA F, FUNAYAMA R, et al. Nrf2-MafG heterodimers contribute globally to antioxidant and metabolic networks[J]. Nucleic Acids Research, 2012, 40(20): 10228-10239.
[3]CHORLEY B N, CAMPBELL M R, WANG X, et al. Identification of novel NRF2-regulated genes by ChIP-Seq: influence on retinoid X receptor alpha[J]. Nucleic Acids Research, 2012,40(15):7416-7429.
[4]AGYEMAN A S, CHAERKADY R, SHAW P G, et al. Transcriptomic and proteomic profiling of KEAP1 disrupted and sulforaphane-treated human breast epithelial cells reveals common expression profiles[J]. Breast Cancer Research and Treatment, 2012, 132(1): 175-187.
[5]MALHOTRA D, PORTALES-CASAMAR E, SINGH A, et al. Global mapping of binding sites for Nrf2 identifies novel targets in cell survival response through ChIP-Seq profiling and network analysis[J]. Nucleic Acids Research, 2010, 38(17): 5718-5734.
[6]MACLEOD A K, MCMAHON M, PLUMMER S M, et al. Characterization of the cancer chemopreventive NRF2-dependent gene battery in human keratinocytes: demonstration that the KEAP1-NRF2 pathway, and not the BACH1-NRF2 pathway, controls cytoprotection against electrophiles as well as redox-cycling compounds[J]. Carcinogenesis, 2009, 30(9): 1571-1580.
[7]PAEK J, LO J Y, NARASIMHAN S D, et al. Mitochondrial SKN-1/Nrf mediates a conserved starvation response[J]. Cell Metabolism, 2012, 16(4): 526-537.
[8]JUNG K A, CHOI B, NAM C W, et al. Identification of aldo-ketoreductases as NRF2-target marker genes in human cells[J]. Toxicology Letters, 2013, 218(1): 39-49.
[9]WU K C, CUI J Y, KLAASSEN C D. Beneficial role of Nrf2 in regulating NADPH generation and consumption[J]. Toxicological Sciences, 2011,123(2):590-600.
[10]VALDECANTOS M P, PRIETO-HONTORIA P L, PARDO V, et al. Essential role of Nrf2 in the protective effect of lipoic acid against lipoapoptosis in hepatocytes[J]. Free Radical Biology and Medicine, 2015, 84: 263-278.
[11]BHALA N, IBRAHIM KAMAL JOUNESS R, BUGIANESI E. Epidemiology and natural history of patients with NAFLD[J]. Current Pharmaceutical Design, 2013, 19(29): 5169-5176.